Please login to the form below

Not currently logged in
Email:
Password:

Japan

This page shows the latest Japan news and features for those working in and with pharma, biotech and healthcare.

Takeda mulls bid for Irish biopharma Shire

Takeda mulls bid for Irish biopharma Shire

Takeda, Japan’s largest pharmaceutical company by sales, has announced that it’s considering a possible takeover deal for Shire, a biopharma focused on rare diseases.

Latest news

More from news
Approximately 43 fully matching, plus 865 partially matching documents found.

Latest Intelligence

  • Significant figures Significant figures

    Olaf said that ALIS’second NDA filing will most likely be in Japan due to its big NTM population and the regular frequency of physicians testing for NTM disease in patients.

  • Deal Watch January 2018

    Under the terms of the agreement Alder receives a non-exclusive global licence (excluding Japan and Korea) to Teva’s CGRP patent portfolio to develop, manufacture and commercialise eptinezumab, its phase

  • The good, the bad and the ugly The good, the bad and the ugly

    Bayer’s growth - a healthy 14.6% - was stimulated by a steady performance by Xarelto in Europe and Asia, and strong sales of its eye medicine Eylea in Japan, Europe and

  • Academic-industry collaboration in the era of big data Academic-industry collaboration in the era of big data

    Institute of Health and Medical Research in France, and Takeda’s with Kyoto University in Japan.

  • A unique ecosystem A unique ecosystem

    In 2018, Medicen will continue its international dynamics with a long-term perspective towards the main ecosystems it already addresses: the US, Canada, Europe, Israel and Japan.

More from intelligence
Approximately 2 fully matching, plus 92 partially matching documents found.

Latest appointments

  • Luis Iglesias heads Santen EMEA Luis Iglesias heads Santen EMEA

    Luis Iglesias has been promoted as Santen’s EMEA head, a move that sees him succeed Shigeo Taniuchi - who returns to Japan to become president and chief operating office of parent

  • Ashfield appoints new leaders in the US and Japan Ashfield appoints new leaders in the US and Japan

    Ashfield appoints new leaders in the US and Japan. Greg Flynn and Mick O’Leary take up regional president roles. ... He has exactly the right expertise and drive to lead CMIC Ashfield and continue our strong progress in Japan.”.

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    Dr Brunn first joined Bayer in 2011 as global head of primary care, based in Beijing, China, and has subsequently served as head of Bayer's pharmaceuticals commercial operations in Japan ... He also brings branding and sales leadership experience from

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    Japan. Having first joined Novartis in 1997 as a general manager in The Netherlands, Cornut has held a number of increasingly senior managerial roles at the Swiss pharma firm, including president

  • Robocath appoints CEO Robocath appoints CEO

    Prior to this, Guy was global vice president of sales and marketing for Europe and Japan with the Sorin Group, and worked at Boston Scientific from 1996 to 2007.

More from appointments
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics